1,7-Heptanediol

We are 1,7-Heptanediol CAS:629-30-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  1,7-Heptanediol
CAS.NO:629-30-1
Synonyms:1,7-DIHYDROXYHEPTANE
1,7-heptandiol
Heptane-1,7-diol
1,7-Heptanediol
1,7-heptadiol
 
Molecular Formula:C7H16O2
Molecular Weight:132.20100
 
Physical and Chemical Properties:
Density:0.951 g/mL at 25 °C(lit.)
Boiling point:259 °C(lit.)
Melting point:17-19 °C(lit.)
Flash point:>230 °F
Index of Refraction:1.455
 
Specification:
Appearance:Colorless liquid
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, Store away from oxidants, reducing agents, acid chlorides, anhydrides, and chloroformates.
Application: Additives for synthetic materials.

1,7-Heptanediol


Related News: The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.2-Bromotriphenylamine CAS:78600-31-4 From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.5-Chloro-2-fluorobenzaldehyde CAS:96515-79-6 Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.Tetrakis(butoxyethoxy)silane In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.

Related Products
Product Name
3-(Chloromethyl)pentane View Details
3,4-Difluorobenzaldehyde View Details
1H,1H,2H,2H-Nonafluorohexyl Methacrylate Cas:1799-84-4 View Details
L(+)-Diethyl L-tartrate manufacturer Tetrabutylammonium hydrogensulfate Cas:32503-27-8 manufacturer Light Stabilizer 119 manufacturer 4-Bromodibenzo[b,d]furan manufacturer Myristoyl Hexapeptide-4 manufacturer